The use of urine-based biomarkers in bladder cancer

Urology

Volumn 67, Issue 3 SUPPL. 1, 2006, Pages 62-64

  Grossman, H Barton ^a,g,h   Blute, Michael L ^b,g   Dinney, Colin P N ^a,g   Jones, J Stephen ^c,g   Liou, Louis S ^d,g   Reuter, Victor E ^e,g   Soloway, Mark S ^f,g  

^a UNIVERSITY OF TEXAS   (United States)

^b MAYO CLINIC   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g ABBOTT LABORATORIES   (United States)

^h PhotoCure   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NUCLEAR MATRIX PROTEIN 22; TUMOR ANTIGEN;

BLADDER CANCER; CANCER GRADING; CANCER SCREENING; CYSTOSCOPY; CYTOLOGY; HEMATURIA; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 33644752831     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.01.036     Document Type: Article

References (5)

1. D. Jocham, F. Witjes, S. Wagner Improved detection and treatment of bladder cancer using hexaminolevulinate imaging a prospective, phase III multicenter study J Urol 174 2005 862 866
2. A.S. Glas, D. Roos, M. Deutekom Tumor markers in the diagnosis of primary bladder cancer a systematic review J Urol 169 2003 1975 1982
3. Y. Lotan, C.G. Roehrborn Sensitivity and specificity of commonly available bladder tumor markers versus cytology results of a comprehensive literature review and meta-analyses Urology 61 2003 109 118
4. M.F. Sarosdy, P. Schellhammer, G. Bokinsky Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer J Urol 168 2002 1950 1954
5. M. Skacel, M. Fahmy, J.A. Brainard Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology J Urol 169 2003 2101 2105